Ganding, Michelle T.

HRN: 21-95-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
CEFUROXIME 1.5GM (VIAL)
10/13/2022
10/20/2022
IV
1.5gm
Q8h
UTI
10/13/2022
CEFUROXIME 500MG (TAB)
10/14/2022
10/20/2022
PO
1 Tab
BID
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: